Epizyme
Patents, Design & Utilities
Last updated:
List of all Epizyme patents 122 in total
| Status | Patent |
|---|---|
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: METHOD OF TREATING CANCER Filling date: 6 Sep 2025 Issue date: 14 Jul 2022 |
Grant | Utility: Combination therapy for treating cancer Filling date: 6 Sep 2025 Issue date: 28 Jun 2022 |
Application | Utility: INHIBITORS OF EZH2 AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: CANCER TREATMENT MODALITIES Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: QUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: EZH2 INHIBITORS FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Grant | Utility: EZH2 inhibitors for treating lymphoma Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: Arginine methyltransferase inhibitors and uses thereof Filling date: 6 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Grant | Utility: EZH2 inhibitors for treating cancer Filling date: 6 Sep 2025 Issue date: 19 Oct 2021 |
Application | Utility: PRMT5 INHIBITORS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: METHOD OF TREATING LEUKEMIA Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: FLOW CYTOMETRY FOR MONITORING HISTONE H3 METHYLATION STATUS Filling date: 6 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Aryl-or heteroaryl-substituted benzene compounds Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Application | Utility: AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: SMYD INHIBITORS Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Grant | Utility: Combination therapy for treating cancer Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: CARM1 INHIBITORS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR Filling date: 6 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Grant | Utility: PRMT5 inhibitors and uses thereof Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: Methods of synthesizing substituted purine compounds Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Application | Utility: ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Method for treating cancer Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: SUBSTITUTED BENZENE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: INHIBITORS OF EZH2 AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 |
Grant | Utility: Method for treating cancer Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Application | Utility: HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Showing 1 to 50 of 122 patents.